Live Breaking News & Updates on Innodem Neurosciences

Stay updated with breaking news from Innodem neurosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eye tracking device for monitoring MS severity approved in Canada

Eye tracking device for monitoring MS severity approved in Canada
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Paul Giacomini , Erin Keith , Diego Mena Mart , Marc Reeves , Innodem Neurosciences , Health Canada , Quebec Division , Eye Tracking Neurological Assessment , Multiple Sclerosis , Novartis Canada , Pad Pro , Expanded Disability Status Scale , Mena Mart ,

INNODEM NEUROSCIENCES' ETNAtm-MS OBTAINS HEALTH CANADA'S APPROVAL

INNODEM NEUROSCIENCES' ETNAtm-MS OBTAINS HEALTH CANADA'S APPROVAL
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Erin Keith , Innodem Neurosciences , Marc Reeves , Neuroscience At Novartis Pharmaceuticals Canada Inc , Health Canada , Novartis Pharmaceuticals Canada Inc , Eye Tracking Neurological Assessment , Multiple Sclerosis , Expanded Disability Status Scale , Pad Pro , Chief Business Officer , Chief Executive Officer , Novartis Pharmaceuticals Canada , Vice President ,

INNODEM NEUROSCIENCES' ETNA™-MS OBTAINS HEALTH CANADA'S APPROVAL

Innodem Neurosciences, a leading digital health and AI company, announced today that its ETNA™-MS has been cleared for commercial use by Health Canada. The Eye Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) is a software as a medical device (SaMD, Class II) intended to administer a non-invasive test and provide an Expanded Disability Status Scale (EDSS) score in the range between 1.0 and 4.5 for use in tracking disease progression in MS patients. ....

Innodem Neurosciences , Marc Reeves , Erin Keith , Novartis Pharmaceuticals Canada Inc , Neuroscience At Novartis Pharmaceuticals Canada Inc , Pad Pro , Chief Business Officer , Chief Executive Officer , Novartis Pharmaceuticals Canada , Vice President , Eye Tracking Neurological Assessment , Eye Movement , Medical Device , Health Canada , Dss Score , I Company , Neurological Assessment , Ovartis Pharmaceuticals Canada Inc , Digital Health ,

Innodem Neurosciences names Chief Medical Officer - Canadian Manufacturing

Dr. Giacomini is a neurologist specializing in multiple sclerosis and neuroinflammatory disorders, as well as advanced neuroimaging techniques. ....

Innodem Neurosciences , Paul Giacomini , Mcgill University , Mcgill University Health Centre , Montreal Neurological Institute , Health Canada , Group Innodem Neurosciences , Chief Medical , Multiple Sclerosis Clinic , Associate Professor , Data Extraction , Multiple Sclerosis To Inform Future Interventions , Pad Pro , Novartis Pharma Canada ,

MS news notes: Vaccines, migraines, eye-tracking technology | Multiple Sclerosis News Today

MS news notes: Vaccines, migraines, eye-tracking technology | Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Marc Reeves , Innodem Neurosciences , Drug Administration , Eye Tracking Neurological Assessment , Novartis Canada ,